Keyphrases
Genome Analysis
100%
DNA Repair
100%
Dietary Restriction
100%
Gene-deficient Mice
100%
Aging
100%
Attenuation
100%
Sarcopenia
100%
ERCC1
27%
Prostaglandin E2
27%
Muscle Quality
27%
Grip Strength
27%
Regeneration
18%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
18%
Oxidative Stress
18%
Muscle Mass
18%
Muscle Growth
18%
Energy Production
18%
Learning Performance
18%
Motor Learning
18%
Motor Coordination
18%
Restriction Effect
18%
Production Pathway
18%
PGF2
18%
Coordination Performance
18%
Clinical Treatment
9%
Low Body Weight
9%
Progeroid
9%
Liver
9%
Age-related Illnesses
9%
Glycolysis
9%
Inflammation
9%
Disability
9%
Gluconeogenesis
9%
Inflammatory Mediators
9%
Potential Biomarkers
9%
Glycogen
9%
Human muscle
9%
Energy Expenditure
9%
Preventive Treatment
9%
Skeletal muscle Mass
9%
Energy Sources
9%
Metabolomics Study
9%
Tricarboxylic Acid Cycle (TCA cycle)
9%
Major Risk Factors
9%
Low Energy
9%
Fructose
9%
9-HODE
9%
Hydroxybutyrate
9%
Inflammatory Indicators
9%
Prostaglandin D2 (PGD2)
9%
Malate
9%
Skeletal muscle Function
9%
Muscle Glycogen
9%
Forelimb
9%
Succinyl-CoA
9%
Thromboxane B2 (TXB2)
9%
Liver Glycogen
9%
Biochemistry, Genetics and Molecular Biology
Metabolomics
100%
DNA Repair
100%
Metabolite
100%
Grip Strength
60%
Oxidative Stress
40%
Body Weight
40%
Liquid Chromatography-Mass Spectrometry
40%
Energy Yield
40%
Muscle Growth
40%
Motor Coordination
40%
Motor Learning
40%
Anti-Inflammatory
40%
Mediator
20%
Gluconeogenesis
20%
Skeletal Muscle
20%
Energy Expenditure
20%
Citric Acid Cycle
20%
Glycogen Liver Level
20%
Succinyl-CoA
20%
Glycogen Muscle Level
20%
Alanine
20%
Fructose
20%
Pharmacology, Toxicology and Pharmaceutical Science
Sarcopenia
100%
Biological Marker
28%
Anti-Inflammatory Drug
28%
Muscle Growth
28%
Inflammation
14%
Alanine
14%
Tricarboxylic Acid
14%
Succinyl-CoA
14%
Malic Acid
14%
Fructose
14%
Hydroxybutyric Acid
14%
Diseases
14%